Medical and Surgical Options for Presbyopia

01/14/22 • 27 min

Drs. Meron Haile and Daniel Choi rejoin the show to break down conventional interventions and newer pharmacologic advances in presbyopia management, including the recently FDA-approved pilocarpine eye drop (Vuity; Allergan).

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Previous Episode

Teprotumumab and Thyroid Eye Disease

Drs. Alison Watson and Seanna Grob review recent data on teprotumumab, the only FDA-approved therapy for thyroid eye disease.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Next Episode

How to Approach Conjunctival, Iris, and Choroidal Lesions

Drs. Maura Di Nicola and Basil Williams map out a systematic approach to assessing ocular lesions, from the front of the eye to the back. The panel discusses primary decisions, such as when to refer, what tests to perform before referral, and how urgently to act.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.